[Treatment of no. II type essential hyperlipoproteinemia with a new therapeutic agent, celluline].
D000328:Adult; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood*; D008747:Methylcellulose / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged
D008074:Lipoproteins; D008747:Methylcellulose
Traitement de l'hyperlipoproténémie essentielle de type II par un nouvel agent thérapeutique, la celluline.